CCEL: Cryo-Cell International, Inc. Company Profile & Statistics

About

CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and presently, their mission of affordability for U-Cord blood preservation remains in effect.

Info & Links

CEO

David Portnoy

Headquarters

700 Brooker Creek Boulevard, Suite 1800
Oldsmar, FL 34677, UNITED STATES

Auditor

Wipfli LLP

Share holders

144

Employees

Cryo-Cell International, Inc. Statistics

Valuation Measures

Market Capitalization²

63.03M

Enterprise Value

73.56M

Enterprise Value/EBITDA(ttm)

-6.42

Price to Earnings Ratio(ttm)

14.63

Price to Sales(ttm)

2.00

Price to Book(mrq)

Price to Cash(ytd)

11.86

Profitability

Gross Margin(ttm)

73.65%

Operating Margin(ttm)

13.76%

Profit Margin(ttm)

-28.45%

Return on Equity(ttm)

-42.06%

Return on Invested Capital(ttm)

288.49%

Return on Assets(ttm)

7.06%

Income Statement

Revenue(ttm)

31.84M

Revenue Per Share(ttm)

3.95

Gross Profit(ttm)

23.45M

EBITDA(ttm)³

-11.46M

Net Income Available to Common(ttm)

-8.93M

Diluted EPS(ttm)

-1.06

Share Statistics

Beta (5Y Monthly)

0.49

52-Week Change

43.50%

S&P 500 52-Week Change

24.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

8.06M

Dividend Yield

12.66%

Float⁴

5.09M

% Held by Insiders

36.86%

% Held by Institutions

10.44%

Balance Sheet

Total Cash(mrq)

2.13M

Total Cash Per Share(mrq)

0.26

Total Debt(mrq)

10.73M

Total Debt/Equity(mrq)

-112.23%

Current Ratio(mrq)

0.61%

Quick Ratio(mrq)

0.57%

Book Value Per Share(mrq)

-1.19

Cash Flow

Operating Cash Flow Per Share(ytd)

0.47

Free Cash Flow(ytd)

1.46M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CCEL

Cryo-Cell International, Inc.

Cryo-Cell International, Inc. Profile